Showing results 1 to 20 of 122
next >
| Issue Date | Title | Author(s) |
| 2018 | 10 W, sub-100 fs fiber amplifier based on a self-referenced 750-MHz Yb:fiber laser frequency comb | Xu, Bo; Ma, Yuxuan; Ishii, Hirotaka; Meng, Fei; Matsushima, Isao; Zhang, Zhigang; Minoshima, Kaoru |
| 11-May-2020 | Active SB-P Versus Conventional Approach to the Protection of High -Risk Side Branches The CIT-RESOLVE Trial | Dou, Kefei; Zhang, Dong; Pan, Hongwei; Guo, Ning; Li, Lang; Li, Yue; Zhang, Qi; Liu, Bin; Shen, Zhujun; Zhang, Bin; Liu, Jian; Han, Wei; Wang, Yang; Zhao, Yanyan; Yang, Yuejin; Chen, Shaoliang; Xie, Lihua; Guan, Changdong; Kirtane, Ajay J.; Xu, Bo |
| 2007 | Activities of Z-ajoene against tumour and viral spreading in vitro | Terrasson, Jerome; Xu, Bo; Li, Min; Allart, Sophie; Davignon, Jean-Luc; Zhang, Li-he; Wang, Kui; Davrinche, Christian |
| 2010 | Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy | Shi, Anhui; Zhu, Guangying; Wu, Hao; Yu, Rong; Li, Fuhai; Xu, Bo |
| 2012 | Angiogenesis inhibition and cell cycle arrest induced by treatment with Pseudolarix acid B alone or combined with 5-fluorouracil | Liu, Jingtao; Guo, Wei; Xu, Bo; Ran, Fuxiang; Chu, Mingming; Fu, Hongzheng; Cui, Jingrong |
| 11-Dec-2021 | Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial | Xu, Bo; Tu, Shengxian; Song, Lei; Jin, Zening; Yu, Bo; Fu, Guosheng; Zhou, Yujie; Wang, Jian'an; Chen, Yundai; Pu, Jun; Chen, Lianglong; Qu, Xinkai; Yang, Junqing; Liu, Xuebo; Guo, Lijun; Shen, Chengxing; Zhang, Yaojun; Zhang, Qi; Pan, Hongwei; Fu, Xiaogang; Liu, Jian; Zhao, Yanyan; Escaned, Javier; Wang, Yang; Fearon, William F.; Dou, Kefei; Kirtane, Ajay J.; Wu, Yongjian; Serruys, Patrick W.; Yang, Weixian; Wijns, William; Guan, Changdong; Leon, Martin B.; Qiao, Shubin; Stone, Gregg W. |
| 2007 | Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma | Yang, Huayu; Guo, Wei; Xu, Bo; Li, Min; Cui, Jingrong |
| 2007 | An anticancer effect of a new saponin component from Gymnocladus chinensis Baillon through inactivation of nuclear factor-kappa B | Ma, Yan-Xia; Fu, Hong-Zheng; Li, Min; Sun, Wan; Xu, Bo; Cui, Jing-Rong |
| 2015 | Anticancer Effect of a Novel Proteasome Inhibitor, YSY01A, via G2/M Arrest in PC-3M Cells in vitro and in vivo | Zhang, Mei; Yuan, Xia; Xu, Bo; Guo, Wei; Ran, Fu-Xiang; Li, Run-Tao; Cui, Jing-Rong |
| 15-Apr-2024 | Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer (Mar, 10.1039/D3MD00752a, 2024) | Zhu, Yuejie; Li, Xiang; Zhang, Qi; Yang, Xiantao; Sun, Xudong; Pan, Yi; Yuan, Xia; Ma, Yuan; Xu, Bo; Yang, Zhenjun |
| 4-Mar-2024 | Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer | Zhu, Yuejie; Li, Xiang; Zhang, Qi; Yang, Xiantao; Sun, Xudong; Pan, Yi; Yuan, Xia; Ma, Yuan; Xu, Bo; Yang, Zhenjun |
| 3-Feb-2021 | Association Between Lipoprotein(a) and Peri-procedural Myocardial Infarction in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention | Liu, Yupeng; Wang, Wenyao; Song, Jingjing; Zhang, Kuo; Xu, Bo; Li, Ping; Shao, Chunli; Yang, Min; Chen, Jing; Tan, Yi-Da |
| 2011 | beta-Escin Sodium Inhibits Inducible Nitric Oxide Synthase Expression via Downregulation of the JAK/STAT Pathway in A549 Cells | Ji, Deng Bo; Xu, Bo; Liu, Jing Tao; Ran, Fu Xiang; Cui, Jing Rong |
| 2015 | Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease ABSORB China Trial | Gao, Runlin; Yang, Yuejin; Han, Yaling; Huo, Yong; Chen, Jiyan; Yu, Bo; Su, Xi; Li, Lang; Kuo, Hai-Chien; Ying, Shih-Wa; Cheong, Wai-Fung; Zhang, Yunlong; Su, Xiaolu; Xu, Bo; Popma, Jeffery J.; Stone, Gregg W. |
| 2009 | Capillary electrophoresis for screening of 20S proteasome inhibitors | Chen, Wenjing; Mou, Ke; Xu, Bo; Ling, Xiaomei; Cui, Jingrong; Xu, Ping |
| 2014 | Clinical effectiveness of recombinant adenovirus-p53 combined with radiotherapy in advanced soft tissue sarcoma: A report of 37 cases | Gang, Jianhao; Xiao, Shaowen; Zhang, Shanwen; Liu, Changqing; Li, Yongheng; Ji, Jiafu; Fang, Zhiwei; Sun, Yan; Su, Xing; Cai, Yong; Xu, Gang; Li, Dongming; Zhu, Guangying; Xu, Bo |
| 2006 | Clinical Trial of Recombinant Adenovirus-p53 (Gendicine) Combined with Radiotherapy in Nasopharyngeal Carcinoma Patients | Zhang, Shanwen; Xiao, Shaowen; Sun, Yan; Liu, Changqing; Su, Xing; Li, Dongming; Xu, Gang; Zhu, Guangying; Xu, Bo |
| 2011 | Combination of Recombinant Adenovirus-p53 with Radiochemotherapy in Unresectable Pancreatic Carcinoma | Li, Jin-luan; Cai, Yong; Zhang, Shan-wen; Xiao, Shao-wen; Li, Xiao-fan; Duan, You-jia; Li, Yong-heng; Xu, Bo; Yan, Kun |
| 2018 | Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial | Xu, Bo; Yang, Yuejin; Han, Yaling; Huo, Yong; Wang, Lefeng; Qi, Xiangqian; Li, Jifu; Chen, Yundai; Kuo, Hai-Chien; Ying, Shih-Wa; Cheong, Wai-Fung; Zhang, Yunlong; Su, Xiaolu; Popma, Jeffery J.; Gao, Runlin; Stone, Gregg W. |
| 10-Feb-2022 | Complex Raman Tensor in Helicity-Changing Raman Spectra of Black Phosphorus under Circularly Polarized Light | Han, Shiyi; Zhao, Yan; Nguyen Tuan Hung; Xu, Bo; Saito, Riichiro; Zhang, Jin; Tong, Lianming |
